Top Stories News

The new facility is set to quadruple the company's HQ plasmid DNA capacity 

The UN agency convened a meeting last week to discuss the outbreak 

A US-based biotech is seeking damages for Pfizer’s use of a patented coronavirus 3CL protease inhibitor in its blockbuster drug Paxlovid  

VLA15 is the only Lyme disease vaccine candidate currently in clinical development 

The vaccines have been adapted to target the Omicron variant, which has been the dominant variant globally since the beginning of the year 

A committee will meet next week to discuss issuing the emergency designation.

The Rwanda site will be the first piece of the company’s African manufacturing network  

Smaller companies targeting rare and extremely specific treatment areas are leading the charge in this emerging market.  

CordenPharma, a full-service CDMO of APIs, Excipients, Drug Products & Packaging services, has increased its xRNA capabilities at its sterile injectable facility in Caponago, Italy. 

Through the entire product lifecycle – production, consumption and disposal – the pharma industry significantly impacts the environment.  

Engagement-based strategy could increase resilience of pharma supply chain. 

Follow along for live updates from CPHI North America, taking place in Philadelphia, PA from May 17-19. 

Robust oversight linked to increased efficiency and better communication with outsourcing partners. 

The jury assessed a wide range of industry-changing innovations in packaging and drug delivery, ultimately selecting seven winners. 

We caught up with MedPharm at CPHI North America to discuss opportunities in the topical and transdermal products space. 

Increased transparency and standardisation in ESG reporting frameworks is emerging as a key requirement for investors. 

Informa Markets colleagues explain the motivations behind CPHI’s rebrand. 

Environmental impact is an area of increasing focus for the pharma and biopharma industries, with companies like Merck, Pfizer and GlaxoSmithKline setting ambitious targets for carbon neutrality and laying plans for waste reduction.   

The Consortium aims to increase the scale of cell therapy manufacturing to a level impossible with current manual processes. 

The first COVID-19 vaccine plant in Africa is at risk of closure due to lack of demand. 

For a full rundown on tech trends driving the sector, catch these five sessions at Pharmapack 2022 

Supply chain disruptions have become the new normal. Recurring pandemic waves, inflation, trade jitters and a war in Europe have done little to quell C-suite anxieties.  

The contract development and manufacturing organisation (CDMO) has completed the first phase of its multi-million-pound development. 

The war in Ukraine has forced companies to suspend or delay clinical trials in the region.

Pharmapack 2022 is just around the corner and judging for its annual awards is already underway. Every year a jury of industry experts assesses a range of products making waves in packaging and drug delivery and ultimately crowns a handful of winners a...

Global mergers and acquisitions hit an all-time high in 2021, and in the life sciences industry these kinds of deals show no sign of slowing down. 

Smart devices are revolutionising how we live our lives and changing the shape of the industries adopting them. One such industry is healthcare, where the benefits of context-aware devices and real-time data sharing are having tangible effects on patie...

Moderna announces up to USD $500 million investment for the construction of mRNA vaccine manufacturing facility in Kenya, the first of its kind on the African continent. The facility will be a significant step towards vaccine equity...

In this month's edition of the CPHI Webinar Series, experts from BioPlan Associates and NIBRT share insights on key trends impacting the biomanufacturing and bioprocessing sector.

Contract development and manufacturing organisation Micro-Sphere has invested more than €1.5 million at its plant in Switzerland to expand its offering in encapsulation for inhalation products.

The biopharmaceutical industry has seen incredible growth in the past decade, and shows no sign of slowing as the need for specialised treatments in oncology, immunology and vaccines continue to grow.

By joining forces, the two companies will be able to bring Dispersome to the market faster for novel drug development

The biopharma industry drives development of complex therapies which improve the health outcomes and quality of life of patients across the globe. It is however a significant contributor to environmental waste and emissions as a direct result of it'...

A diverse range of sectors and industries come together in partnership to address infection management, advocating a whole system approach

COVID-19 saw biopharma turn to single-use technology in a big way. But greater use of disposable manufacturing systems does not necessarily mean drug and vaccine production has become less environmentally sustainable.

Samsung Biologics has reached an agreement for the buyout of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion.

The medical journal highlights antimicrobial resistance (AMR) to be a 'leading cause of death around the world'.

Lagevrio and Paxlovid are the only COVID-19 pills cleared for emergency use at present, but others are coming with developers racing to bring oral antivirals to this potentially lucrative market.

We are approaching the end of a year which saw global vaccine rollout for COVID-19, 44 novel drug approvals (to date) and the return of the CPHI Worldwide in-person event.

CDMO currently manufacturing LAAB combination treatment  and will start on cancer immunotherapy product from next year

CPHI has launched its forward-looking pharma trend report for 2022 and it is now available to read on CPHI Online.

The combined company intends to lead in the space of oral formulations, solving customers' complex formulation challenges

It could take pharmaceutical companies months to tweak their COVID-19 vaccines to provide sufficient protection against the Omicron variant of the coronavirus if it poses a risk of serious illness.

The offering will accelerate timelines for the development and manufacturing of molecules and disruptive technologies

The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing

In this special edition podcast, Informa Markets pharma editor Gareth Carpenter speaks to Bikash Chatterjee, CEO at Pharmatech Associates and Dan Stanton, Editor and Founder at BioProcess International about some of the findings in the recently pu...

The transaction expands ANI’s R&D pipeline and adds nine new customers to its growing CDMO business

China is the pharma industry’s biggest gainer in the 2021 CPHI Annual Rankings, with digital matchmaking driving new waves of partnerships

CPHI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark

The proposed state-of-the-art facility could potentially produce up to 100 million vaccine doses each year for Australians

Awards seek to recognise ‘Excellence in Pharma’, assessing entries from the industry’s leading companies and individuals.

The increasing outsourcing trend among pharmaceutical companies represents a promising opportunity for CDMOs. This panel discussion at CPHI Worldwide touched upon some of the opportunities, hurdles, and trends ahead for the CDMO market

The concept of patient centricity has many nuances, and designing dosage forms needs to be underpinned by a multi-functional perspective utilised as early as possible, say experts

Rather than looking back at what has been a challenging past few months, this Trend Report - featuring highlights from the Pharmapack 2021 content programme - has been written very much in the spirit of looking forward and addressing the key challenges...

Rise of innovative companies with high-risk portfolios will necessitate need for CDMOs, says Thermo Fisher senior executive

COVID-19 pandemic has exposed weaknesses and sector faces new challenges driven by rising costs of production in China

Current EU regulatory systems too overwhelmed by paper, head of European association representing generics, biosimilars and value added medicines industries tells CPHI Worldwide online conference

Country expected to grow threefold over the next decade due to increased focus on complex generics, biosimilars and specialty products

According to unnamed sources in Politico report, company’s vaccine batches have not met FDA purity level standards

UCB Pharma is informed by agency that action on application for psoriasis treatment is being deferred until on-site visits can be made

Manufacturer starts development of API for molnupiravir, which is set to become world’s first oral treatment against coronavirus

Awards showcased a wide range of industry-changing innovations in packaging and drug delivery, with sustainability emerging as a key metric across all categories

Panel discusses how healthcare institutions are adapting to calls for more sustainability in various processes in the value chain

Pre-filled syringes (PFS) could help immensely in solving the challenges of rolling out future mass vaccination campaigns, according to experts at Becton Dickinson (BD).

During the live Innovation in Connectivity Roundtable at the Pharmapack 2021 online conference, experts discussed how the latest innovations in digital technology are shaping industry ambitions to put the patient journey at the heart of its drug device...

The LSCC provides an additional 30% in mammalian large-scale capacity for the company's own pipeline and for third parties

Just as 'food miles' have become a key concern among consumers in recent years, patients now want to know more about 'medicine miles', study commissioned by Teva finds

Electronic devices and connectivity are being progressively included in drug delivery devices, bringing positive outcomes to all stakeholders, according to drug device combinations specialist, Nemera Tuesday

Quantum computing technology uses quantum systems called “qubits”. They work with non-binary values, unlike classical computing which uses only bits with values of 0 or 1, and can overlap each other and act as a group. The result is a ...

The company plans to open a new 130,000-sq. ft plant in Ann Arbor in late 2023

The acquisition will add 13 approved products and additional pipeline products

The transaction is expected to accelerate Catalent's growth in global softgel and oral dose formulation and manufacturing services

Today, Informa Markets is pleased to announce the launch of the all-new CPHI Online Dashboard, which will allow CPHI clients to quickly and easily track awareness and interest in their company, products and content as well as view and download leads to...

As CDMOs seek to diversify their business models, is a full-service offering the holy grail or is there a danger of biopharmaceutical outsourcing firms becoming the jack of all trades and the master of none?

The CDMO, through its recent acquisition of IsiSys, will help to advance BICX104 toward first-in-human clinical trials

Opportunities for CDMO expansion are extending to Latin America and Africa, say experts

Companies say earlier collaboration may speed development and introduction of targeted precision medicine therapies for patients.

£35 million public-private collaboration to develop next-generation pharmaceutical manufacturing processes to drive forward innovation in the medicines supply chain

The CDMO inaugurates its new analytical laboratory under Recipharm Analytical Solutions

Pfizer and BioNTech’s shot on Monday became the first COVID-19 vaccine to be granted full approval by the US Food and Drug Administration.

Firms say the partnership will "multiply the power of both companies, the pharmaceutical industry and the medical cannabis industry"

Innovation is the cornerstone of the drug delivery technology sector; efforts to make therapies more convenient for patients, reduce side effects and differentiate products from the competition have always made the delivery sector a hotbed of new ideas...

The CPHI North America exhibition is taking place in-person this week in Philadelphia from 10-12 August. Here we take a look at key learnings from the past two weeks of expert-led content, available to all attendees as part of the hybrid event experien...

Tech transfer is a crucial phase that converts clinical promise into commercial gain but pressure on sponsors to reduce time to market in the age of COVID-19 means CDMOs have to be on top of their game to deliver. What are the latest innovations to sol...

Explore the series of Learning Labs at CPHI North America in which thought leaders at our exhibitors showcase their extensive knowledge on all areas of the pharma supply chain, offering industry insights across drug manufacturing, outsourcing, pharma i...

Explore the series of Learning Labs at CPHI North America across several product innovation categories in which thought leaders at our exhibitors showcase their extensive expertise in all areas of the pharma supply chain, offering industry insight...

Opportunities for contract development and manufacturing organisations (CDMOs) in China continue to grow but many questions remain over what the future of the sector will look like in the world's second largest pharmaceutical market.

CDMOs need to diversify and expand their capabilities to take full advantage of strong growth in prominent end markets such as small molecule, monoclonal antibodies and cell and gene therapy, according to an industry expert on a panel at the CPHI North...

Speaking at CPHI North America, Dr Scott Gottlieb shares insights into how the US should prepare for future pandemics by building out vaccine capacities

Transformative technologies and the opportunities afforded by the COVID-19 pandemic have spurred investment in the life sciences outsourcing sector, according to a panel of industry experts speaking at CPHI North America on Monday.

Accelerated efforts align with the Paris Agreement and Race To Zero to combat climate change

The combined capabilities will offer flexibility and innovation from small-scale biosimilar development through to large-scale manufacturing

More than 350,000 health apps are currently available, increasingly focused on helping them manage their conditions rather than on wellness management

The rise in the concept of ‘self-care’ has forced the beauty and cosmetics industry to think differently about how they launch their products. Martin Oxley, Managing Director at buzzback explains why the cosmeceuticals sector does not just ...

As more and more companies operating in the pharmaceutical space are moving into cosmetics, the temptation is to think that life will be much easier from a regulatory and compliance perspective.

Pharma firm tells FDA tech transfer to its own facility in Schaftenau, Austria is underway after regulator highlighted concerns about third party CDMO site in Italy

Watch this CPHI Webinar sponsored by PharmaVentures, in which a broad panel of experts across the pharmaceutical manufacturing space discussed how M&A activity is being shaped by this ever evolving and complex sector

The market for CBD is growing and it is not just the pharmaceutical industry that is exploring its potential. Martin Oxley, MD at buzzback UK explains how consumer interest in plant-based ingredients and natural products present huge opportunities for ...

While the COVID-19 pandemic has created even greater demand for partnerships, CDMOs need to be aware that the needle has shifted, creating both opportunities and challenges and changing how the services industry does business

Drug categories impacted by travel restrictions expected to see higher sales levels in FY22

During CPHI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – we spoke with Doug Hausner, Senior Manager Continuous Manufacturing at Thermo Fisher Scientific. He presented his views on how continuous ma...

New $30 million manufacturing facility in Burlington, Ontario, will allow company to manage R&D in-house and scale production without reliance on third-party manufacturers

The initial outbreak of the COVID-19 pandemic delayed merger and acquisitions in the pharma sector, but evidence points to an uptick in activity because the rationale for sealing deals hasn’t changed

CPHI Discover (May 17-28) gave Pharma companies, suppliers and service providers the opportunity to keep potential buyers and partners abreast of the latest news, product information and market trends in the form of free-to-access, downloadable content...

Drug substance production line expected to be operational by end of 2021 as part of CDMO’s expanded collaboration with biotech

CPHI Discover webinar examines the progress made so far in terms of vaccine distribution to the global population as well as anticipating future challenges

Bookmark this page for regular updates on the rich variety of content coming your way via CPHI Discover, pharma’s largest ever virtual gathering, over the course of our three-day agenda

Partnering with one of northern Europe’s oldest academic universities, Lund University in Sweden, Pharmapack has launched this three-part podcast series, delivering the latest insights on medication packaging innovation and the gathering momentum...

Coronavirus pandemic has exacerbated manufacturing capacity constraints, particularly in injectable dose and viral vector production, CPHI audience told

Strong and effective partnerships with CDMOs are essential to success due to the complexity of manufacturing processes

The UK’s withdrawal from the European Union has meant the pharmaceutical industry has had to adapt to some monumental changes in terms of research, regulatory affairs, and trade. In this CPHI Webinar, three industry experts discussed what the fut...

Our virtual CPHI Discover event (17th-28th May) is just around the corner, full to the brim with three main content tracks. Here, we explore the major trends in APIs, Ingredients & Formulation

Our virtual CPHI Discover event (17th-28th May) is just around the corner, full to the brim with three main content tracks. Here, we explore the major trends in Drug Delivery and Packaging.

Our virtual CPHI Discover event (17th-28th May) is just around the corner, full to the brim with three main content tracks. Here, we explore the major trends and issues surrounding Manufacturing and Outsourcing.

New facility at Gosselies site will host commercial scale pDNA manufacturing as Catalent extends its cell and gene therapy footprint

Ahead of the session, How will the New Administration Impact the US Pharma Market? at CPHI Discover on Tuesday 18th May – global pharma’s largest ever virtual gathering – we spoke with one of the speakers, Nielsen Hobbs...

CHF 200 million investment will include dedicated line for antibody-drug conjugate payload molecules and is scheduled to start operations in Q3 2023

With CPHI North America fast approaching, we ask Karen Flynn (President, Biologics & Chief Commercial Officer, at Catalent), Hamilton Lenox (Senior Vice President of Business Development, Sales & Marketing, at LGM Pharma), and Mike Kleppinger, Chief Co...

What are the major implications of any drive to reshore US pharmaceutical manufacturing, given that current Asian domination is based on cost savings and capacity? We ask the experts...

Company failed to investigate vaccine drug substance discrepancies thoroughly, says US regulator